Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1

Conditions

Anemia 2Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Iron Deficiencies 1Hematologic Neoplasms 1Gynecologic Cancer 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Anemia, Iron-Deficiency 1Anaemia in Ovarian Carcinoma 1

Interventions

ferric carboxymaltose 4iron isomaltoside 1000 3ferric derisomaltose 2Iron-Dextran Complex 2ferroglycine sulfate 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Sodium Chloride 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Niferex 1Gastroscopy 1Ferric Oxide, Saccharated 1Control Groups 1Colonoscopy 1Colonography, Computed Tomographic 1Betaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anemia, Iron-Deficiency × Ferric Oxide, Saccharated × Clear all
NCT03933813 2023-01-05

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

University of Wisconsin, Madison

Phase 1/2 Terminated
9 enrolled
Classical hematologyGynecologic

Carcinoma, Ovarian Epithelial, Iron Deficiencies, Anemia, Ovarian Neoplasms, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡